Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
441 N Lakeview Ave
Anaheim, CA 92807Phone+1 888-988-2800Fax+1 877-514-0903
Education & Training
Kaiser Permanente Southern California (Los Angeles)Residency, Radiology-Diagnostic, 1998 - 2003
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2025- American Board of Radiology Diagnostic Radiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 36 citationsEFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis.Chi-Chen Fan, Sheng-Ta Tsai, Chen Yuan Lin, Ling-Chu Chang, Juan-Cheng Yang
Redox Biology. 2020-07-01 - 9 citationsInhibition of Arachidonate 12/15-Lipoxygenase Improves α-Galactosidase Efficacy in iPSC-Derived Cardiomyocytes from Fabry Patients.Yueh Chien, Shih Jie Chou, Yuh Lih Chang, Hsin Bang Leu, Yi Ping Yang
International Journal of Molecular Sciences. 2018-05-16 - 1 citationsPublisher Correction: EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma.Chi Chen Fan, Wei-Chung Cheng, Yu Chuen Huang, Yuh Pyng Sher, Nia Jhen Liou
Scientific Reports. 2018-01-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
